Blood News and Research

RSS

Sanitization error might possibly have exposed hundreds to HIV at Indiana hospital

An Indiana hospital is in the news for all the wrong reasons. An accidental failure by one of the seven sterilization technicians working at the hospital was recently discovered. The technician failed to carry out a single step in a protocol concerning the sanitization of surgical equipment at Goshen Hospital, over a period from April 1 to September 30.

26 Nov 2019

Novel diagnostic method for rapid measurement of celiac disease antibodies

Point-of-care testing is a rapidly growing sector, bringing medical testing from central laboratories to where the patient is receiving care.

26 Nov 2019

Attacking HIV at the source

A new study published on November 26, 2019, in the journal Cell Reports, details a new discovery that may help avert HIV infection right at the start. The virus is known to take a long time to infect a person, and the scientists say they have found a period during which it can be weakened or killed, in the very first hours after it has entered a host. They call this the window of vulnerability.

26 Nov 2019

Research could help design better flu vaccines

Each year millions of Americans become sick with the flu, hundreds of thousands are hospitalized and tens of thousands die. Getting the flu shot can reduce the chances of infection. But, at best, the vaccine is only effective 40% to 60% of the time, according to the CDC.

26 Nov 2019

Looking for the source: new routes for allergy treatment

A new multinational study has reported a very full account of the B lymphocytes that produce group E antibodies, also called IgE (Immunoglobulin E), that are behind allergic reactions, which are common in up to a third of the world’s population.

26 Nov 2019

Oligomerix and Feinstein Institutes publish preclinical data of Alzheimer's disease treatment

Oligomerix, Inc., a privately held company pioneering the development of tau oligomer inhibitors for Alzheimer's disease and related neurodegenerative disorders, and the Feinstein Institutes for Medical Research announced today the publication of preclinical data demonstrating that an oral small molecule drug inhibits the formation of neurotoxic tau oligomers in an animal model of tau aggregation most relevant to AD.

26 Nov 2019

New wearable sensor for non-invasive gout detection

Biomedical scientists are working hard to create more pain-free methods of disease detection and treatment. A simple blood test is highly informative but arouses intense anxiety in many people. Now a new paper published in the journal Nature Biotechnology on November 25, 2019, reports on a new wearable sensor that can be successfully adapted to mass production, is flexible, and can be used to produce readouts of metabolites and nutrients in the blood based on a sweat analysis.

26 Nov 2019

Aerobic exercise and heart-healthy diet may slow cognitive decline in older adults with CIND

Cognitive impairment without dementia (CIND), or mild cognitive impairment, is a condition that affects your memory and may put you at risk for Alzheimer's disease and dementia.

26 Nov 2019

Simple precautions to avoid food poisoning during the holiday season

Preparing a holiday feast can begin as soon as you get home from the grocery store. But if you want to serve family and friends a delicious meal that keeps them coming back for more, food safety guidelines need to be part of the recipe.

26 Nov 2019

Few things to know before buying at-home genetic testing kits

At-home genetic testing kits, also known as direct-to-consumer or lab-to-consumer DNA tests, are growing in popularity - especially as holiday gifts.

26 Nov 2019

Mercy Medical Center to establish the Maryland Bariatric Center

Noted bariatric specialist Kuldeep Singh, MD, FACS, MBA, FASMBS, has joined Mercy Medical Center to establish a new clinical program: The Maryland Bariatric Center at Mercy, scheduled to open in January 2020. Dr. Singh will lead the new center as Medical Director.

26 Nov 2019

Validation of new method for studying how different drugs interact in the body

Scientists at Oregon State University may have proven how much people love coffee, tea, chocolate, soda and energy drinks as they validated their new method for studying how different drugs interact in the body.

26 Nov 2019

Giving a shot of ketamine could help heavy drinkers reduce alcohol intake

A one-off dose of ketamine could help heavy drinkers reduce their alcohol intake, finds a new UCL experimental study.

26 Nov 2019

Innovative migraine prophylaxis could endanger people with chronic high blood pressure

The neuropeptide αCGRP (α calcitonin gene-related peptide) works in two different ways. It leads to inflammation and dilates the blood vessels right at the release point of the nerve cells, for example in the meninges, which can trigger migraine attacks. However, it has a completely different effect on the heart, as has now been discovered by a team of researchers at the University of Zurich.

26 Nov 2019

Stem cells do not take the day off on national holidays

While most of us are stuffing ourselves with turkey and pumpkin pie at home on Thanksgiving Day, the staff at one Cedars-Sinai laboratory will be on the job, feeding stem cells.

26 Nov 2019

Broadly expressed metabolic approach could make sarcoma susceptible to targeted therapies

Soft tissue sarcoma cells stop a key metabolic process which allows them to multiply and spread, and so restarting that process could leave these cancers vulnerable to a variety of treatments.

26 Nov 2019

New way to thwart HIV infection at early stages

1.7 million. That's how many people are infected with the human immunodeficiency virus (HIV) each year worldwide. 1.7 million people who are condemned to lifelong antiretroviral therapy (ART) or risk developing fatal AIDS . Out of the 37.9 million people living with HIV (PLWH), 22.3 million have access to ART, allowing them to have an almost normal lifespan.

26 Nov 2019

Sheffield research receives £800k to develop new gene therapy to treat CVD

Cardiac research in Sheffield has received a major boost from the British Heart Foundation in the form of an £800,000 award to develop a new gene therapy to treat cardiovascular disease (CVD).

26 Nov 2019

Key mechanism identified for how antiviral immune responses reprogram liver metabolism

Researchers at the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences identified a key mechanism for how antiviral immune responses reprogram liver metabolism. Their recent study, which was published in the renowned scientific journal Immunity, investigated the communication between inflammation and liver metabolism during chronic viral infection.

26 Nov 2019

Studying the genomes of hibernating mammals could improve understanding and treatment of obesity

A discovery about mammalian genomes and hibernation could aid understanding and treatment of obesity and metabolic disorders.

26 Nov 2019

Blood News and Research

Sanitization error might possibly have exposed hundreds to HIV at Indiana hospital

Novel diagnostic method for rapid measurement of celiac disease antibodies

Attacking HIV at the source

Research could help design better flu vaccines

Looking for the source: new routes for allergy treatment

Oligomerix and Feinstein Institutes publish preclinical data of Alzheimer's disease treatment

New wearable sensor for non-invasive gout detection

Aerobic exercise and heart-healthy diet may slow cognitive decline in older adults with CIND

Simple precautions to avoid food poisoning during the holiday season

Few things to know before buying at-home genetic testing kits

Mercy Medical Center to establish the Maryland Bariatric Center

Validation of new method for studying how different drugs interact in the body

Giving a shot of ketamine could help heavy drinkers reduce alcohol intake

Innovative migraine prophylaxis could endanger people with chronic high blood pressure

Stem cells do not take the day off on national holidays

Broadly expressed metabolic approach could make sarcoma susceptible to targeted therapies

New way to thwart HIV infection at early stages

Sheffield research receives £800k to develop new gene therapy to treat CVD

Key mechanism identified for how antiviral immune responses reprogram liver metabolism

Studying the genomes of hibernating mammals could improve understanding and treatment of obesity

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News